Science Explorer Interactive view Map
Company · Brussels · Belgium

UCB Pharma (Belgium)

In research, UCB Pharma (Belgium) stands highest in Medicine (#7,421 of 10,443 worldwide) and Health Sciences (#9,002 of 11,982 worldwide), 2022–2025.

ucb.comROR OpenAlex
World rank, 2022–2025
#10,995
of 28,054 · #6,620 all time
Rank in Belgium
#59
of 138
Research works
1.2k
▼ 13% vs 2013–17
Citations
37k
31.1 per fractional work
Top-10% rate
17.2%
record average 16.5%
Open access
35%
world 28%

What is UCB Pharma (Belgium) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #7,421 of 10,443 18.4%83 #3679
Health SciencesDomain #9,002 of 11,982 18.7%88 #4948

Each strip is that field’s whole ranked pool, with the notch where UCB Pharma (Belgium) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.90× its world share, 17 worksBiochemistry, Geneti…Immunology and Microbiology: 5.48× its world share, 9 worksImmunology and Micro…Neuroscience: 3.79× its world share, 10 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.38× its world share, 4 worksPharmacology, Toxico…Chemical Engineering: 1.40× its world share, 1 worksChemical EngineeringChemistry: 2.46× its world share, 7 worksChemistryComputer Science: 0.41× its world share, 6 worksComputer ScienceEnergy: 0.04× its world share, 0 worksEnergyEngineering: 0.35× its world share, 9 worksEngineeringEnvironmental Science: 0.08× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.40× its world share, 2 worksMaterials ScienceMathematics: 0.68× its world share, 1 worksMathematicsPhysics and Astronomy: 0.27× its world share, 1 worksPhysics and AstronomyDentistry: 0.71× its world share, 1 worksDentistryHealth Professions: 0.53× its world share, 2 worksHealth ProfessionsMedicine: 2.55× its world share, 83 worksMedicineNursing: 0.66× its world share, 0 worksNursingVeterinary: 4.35× its world share, 1 worksVeterinaryArts and Humanities: 0.10× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.14× its world share, 1 worksBusiness, Management…Decision Sciences: 1.02× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 1.82× its world share, 7 worksEconomics, Econometr…Psychology: 0.31× its world share, 2 worksPsychologySocial Sciences: 0.08× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.4×. Every wedge is a field page.

Who are the top researchers at UCB Pharma (Belgium)?

Ranked on the composite score, B. B. Fuks, Martin J. Weiss and Keyang Xu lead among researchers whose main affiliation is UCB Pharma (Belgium).

  1. 1 B. B. Fuks Belgium · #328,307 worldwide 183 citations · 15 works
  2. 2 Martin J. Weiss Belgium · #389,295 worldwide 137 citations · 46 works
  3. 3 Keyang Xu Belgium · #438,740 worldwide 89 citations · 18 works
  4. 4 R. Massingham Belgium · #814,033 worldwide 53 citations · 16 works
  5. 5 Martyn Wood Belgium · #916,827 worldwide 70 citations · 18 works
  6. 6 D Toussaint Belgium · #944,368 worldwide 20 citations · 39 works
  7. 7 Stefanie Dedeurwaerdere Belgium · #988,992 worldwide 43 citations · 18 works
  8. 8 J.G. Gobert Belgium · #1,042,781 worldwide 11 citations · 15 works
  9. 9 Adrian Hall Belgium · #1,371,002 worldwide 27 citations · 18 works
  10. 10 Armel Stockis Belgium · #1,413,510 worldwide 18 citations · 15 works
All ranked researchers at UCB Pharma (Belgium)

Which keywords describe research at UCB Pharma (Belgium)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Quality of Life, Antiepileptic Drugs, Autoantibodies, Genetics, Neurological Disorders, Monoclonal Antibodies and Neurobiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation14▲ 4.0×31 topics
  2. Quality of Life11▲ 4.3×15 topics
  3. Epidemiology10▲ 1.47×44 topics
  4. Oxidative Stress8▲ 3.0×17 topics
  5. Antiepileptic Drugs8▲ 62×2 topics
  6. Genetics8▲ 6.8×9 topics
  7. Autoantibodies8▲ 20×7 topics
  8. Neurological Disorders7▲ 7.6×14 topics
  9. Monoclonal Antibodies7▲ 45×3 topics
  10. Epilepsy7▲ 37×4 topics
  11. Neurobiology7▲ 16×5 topics
  12. Surgery6▲ 11×3 topics
  13. Parkinson's Disease6▲ 14×7 topics
  14. Drug Resistance6▲ 12×6 topics
  15. Neurodegeneration6▲ 11×8 topics
  16. Classification6▲ 7.1×3 topics
  17. Cytokines5▲ 11×5 topics
  18. Biopharmaceuticals5▲ 61×3 topics
  19. Immune System5▲ 13×3 topics
  20. Regulatory T Cells5▲ 27×3 topics
  21. Seizures5▲ 51×1 topic
  22. Status Epilepticus5▲ 67×1 topic
  23. TGF-ß5▲ 20×3 topics
  24. Ankylosing Spondylitis5▲ 107×1 topic
  25. Spondyloarthritis5▲ 107×1 topic
  26. Immunogenicity5▲ 68×2 topics
  27. Medicinal Chemistry5▲ 11×7 topics
  28. IL-175▲ 86×1 topic
  29. TH17 Cells5▲ 86×1 topic
  30. Pharmacokinetics5▲ 11×4 topics
  31. Rheumatoid Arthritis5▲ 29×2 topics
  32. Cost-effectiveness Analysis4▲ 31×1 topic
  33. Health Utility Measures4▲ 31×1 topic
  34. Therapeutic Antibodies4▲ 38×2 topics
  35. Cardiovascular Risk4▲ 8.3×5 topics
  36. Immunosuppressive Therapy4▲ 14×6 topics
  37. Biological Therapy4▲ 43×2 topics
  38. Disease-Modifying Antirheumatic Drugs4▲ 48×1 topic
  39. Joint Inflammation4▲ 48×1 topic
  40. Mitochondrial Dysfunction4▲ 8.1×9 topics

Which research topics does UCB Pharma (Belgium) publish most on?

By volume in 2022–2025: Epilepsy research and treatment, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis and Health Systems, Economic Evaluations, Quality of Life.

Epilepsy research and tr…5Epilepsy research and treatment: 5 fractional worksSpondyloarthritis Studie…5Spondyloarthritis Studies and Treatments: 5 fractional worksPsoriasis: Treatment and…5Psoriasis: Treatment and Pathogenesis: 5 fractional worksHealth Systems, Economic…4Health Systems, Economic Evaluations, Quality of Life: 4 fractional worksRheumatoid Arthritis Research and Therapies: 4 fractional worksComputational Drug Discovery Methods: 4 fractional worksHidradenitis Suppurativa…3Hidradenitis Suppurativa and Treatments: 3 fractional worksPharmacological Effects …3Pharmacological Effects and Toxicity Studies: 3 fractional worksParkinson's Disease Mech…3Parkinson's Disease Mechanisms and Treatments: 3 fractional worksProtein purification and…2Protein purification and stability: 2 fractional works
Psychiatry and Mental healthRheumatologyImmunologyEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epilepsy research and treatment Psychiatry and Mental health 5 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 5 works
  3. 3 Psoriasis: Treatment and Pathogenesis Immunology 5 works
  4. 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  5. 5 Rheumatoid Arthritis Research and Therapies Rheumatology 4 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 4 works
  7. 7 Hidradenitis Suppurativa and Treatments Dermatology 3 works
  8. 8 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 3 works
  9. 9 Parkinson's Disease Mechanisms and Treatments Neurology 3 works
  10. 10 Protein purification and stability Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 28% of research is openly available.

with international co-authors48.7%domestic only51.3%

World: 19% is written across borders.

How has UCB Pharma (Belgium)'s research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Brussels

All research institutions in Brussels

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.